1. A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib. (February 2016) Authors: Kodityal, Sandeep; Elvin, Julia A.; Squillace, Rachel; Agarwal, Nikita; Miller, Vincent A.; Ali, Siraj M.; Klempner, Samuel J.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 92(2016) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A user's guide to lorlatinib. (July 2020) Authors: Nagasaka, Misako; Ge, Yubin; Sukari, Ammar; Kukreja, Geetika; Ou, Sai-Hong Ignatius Journal: Critical reviews in oncology/hematology Issue: Volume 151(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial. Issue 2 (February 2016) Authors: Shaw, Alice T; Gandhi, Leena; Gadgeel, Shirish; Riely, Gregory J; Cetnar, Jeremy; West, Howard; Camidge, D Ross; Socinski, Mark A; Chiappori, Alberto; Mekhail, Tarek; Chao, Bo H; Borghaei, Hossein; Gold, Kathryn A; Zeaiter, Ali; Bordogna, Walter; Balas, Bogdana; Puig, Oscar; Henschel, Volkmar; Ou... Journal: Lancet oncology Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alectinib induced CNS radiation necrosis in an ALK + NSCLC patient with a remote (7 years) history of brain radiation. (June 2016) Authors: Ou, Sai-Hong Ignatius; Weitz, Michael; Jalas, John R.; Kelly, Daniel F.; Wong, Vanessa; Azada, Michele C.; Quines, Oliver; Klempner, Samuel J. Journal: Lung cancer Issue: Volume 96(2016) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Alectinib Induces a Durable (>15 Months) Complete Response in an ALK-Positive Non-Small Cell Lung Cancer Patient Who Progressed on Crizotinib With Diffuse Leptomeningeal Carcinomatosis. (7th January 2015) Authors: Ou, Sai-Hong Ignatius; Sommers, Karen R.; Azada, Michele C.; Garon, Edward B. Journal: Oncologist Issue: Volume 20:Number 2(2015) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L858R/ T790M/G796S) in cis. (February 2022) Authors: Nagasaka, Misako; Balmanoukian, Ani S.; Madison, Russell; Zhang, Shannon S.; Klempner, Samuel J.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 164(2022) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy. (June 2022) Authors: Minchom, Anna; Viteri, Santiago; Bazhenova, Lyudmila; Gadgeel, Shirish M.; Ou, Sai-Hong Ignatius; Trigo, José; Bauml, Joshua M.; Backenroth, Daniel; Bhattacharya, Archan; Li, Tracy; Mahadevia, Parthiv; Girard, Nicolas Journal: Lung cancer Issue: Volume 168(2022) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutation. (October 2018) Authors: Klempner, Samuel J.; Gowen, Kyle; Lee, Thomas K.; Zhu, Viola W.; Schrock, Alexa B.; Miller, Vincent A.; Ali, Siraj M.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 124(2018) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient. Issue 2 (February 2015) Authors: Lu, Stephanie; Azada, Michele C.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient. Issue 2 (February 2015) Authors: Lu, Stephanie; Azada, Michele C.; Ou, Sai-Hong Ignatius Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗